Development Level

Tbio 6 | 10,625
Tchem 1 | 1,890

Disease

Obesity 6 | 616
diabetes mellitus 6 | 1,663
Cancer 5 | 2,346
Hyperglycemia 5 | 120
Hypertension 5 | 287
Metabolic syndrome X 5 | 155
Schizophrenia 5 | 501
Alzheimer's disease 4 | 644
Anorexia nervosa 4 | 59
Arthritis 4 | 248
Asthma 4 | 349
Cerebrovascular disease 4 | 231
Epilepsy 4 | 346
Heart disease 4 | 279
Hyperinsulinism 4 | 63
Osteoporosis 4 | 257
Seizures 4 | 95
Alcohol dependence 3 | 107
Allergic hypersensitivity disease 3 | 123
Amenorrhea 3 | 60
Anovulation 3 | 20
Autistic Disorder 3 | 320
Cocaine-Related Disorders 3 | 88
Fatty Liver 3 | 48
Hyperandrogenism 3 | 32
Hypertensive disease 3 | 193
Hyperthyroidism 3 | 50
Hypoglycemia 3 | 81
Hypogonadism 3 | 70
Hypothyroidism 3 | 89
Infertility 3 | 163
Kidney disease 3 | 396
Liver disease 3 | 219
Major Depressive Disorder 3 | 106
Migraine 3 | 79
Neuropathy 3 | 210
Polycystic Ovary Syndrome 3 | 332
Weight decreased 3 | 18
psoriasis 3 | 6,685
Acanthosis nigricans 2 | 14
Acromegaly 2 | 40
Addison's disease 2 | 29
Adenoma 2 | 165
Anxiety Disorders 2 | 37
Anxiety disorder 2 | 22
Atherosclerosis 2 | 275
Autonomic neuropathy 2 | 21
Bipolar Disorder 2 | 266
Bulimia nervosa 2 | 15
Coronary artery disease 2 | 240
Cushing's syndrome 2 | 47
Dementia 2 | 129
Depressive disorder 2 | 48
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Eating disorder 2 | 24
Edema 2 | 38
Fatty liver disease 2 | 84
Heart failure 2 | 80
Hepatitis C 2 | 90
Heroin dependence 2 | 30
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hyperprolactinemia 2 | 22
Hypersensitivity reaction type II disease 2 | 235
Hypertrophic Cardiomyopathy 2 | 56
Hypokalemia 2 | 40
Hypopituitarism 2 | 36
Hypotension 2 | 53
Inflammatory bowel disease 2 | 142
Insulin Resistance 2 | 48
Klinefelter's syndrome 2 | 59
Lipid metabolism disorder 2 | 102
Lipodystrophy 2 | 32
Liver Cirrhosis, Experimental 2 | 108
Liver Failure, Acute 2 | 22
Lung disease 2 | 132
Memory Disorders 2 | 36
Myopathy 2 | 128
Obstructive sleep apnea 2 | 28
Pain agnosia 2 | 99
Phaeochromocytoma 2 | 20
Pituitary adenoma 2 | 35
Prader-Willi syndrome 2 | 45
Prostatic Neoplasms 2 | 471
Proteinuria 2 | 63
Rhinitis 2 | 46
Substance Withdrawal Syndrome 2 | 52
Tachycardia 2 | 17
Weight Gain 2 | 87
Withdrawal disorder 2 | 19
adult high grade glioma 2 | 2,148
breast carcinoma 2 | 1,614
glioblastoma 2 | 5,572
ovarian cancer 2 | 8,484
Carney complex 1 | 23
Congenital hypothyroidism 1 | 20
Epilepsy, Temporal Lobe 1 | 23
Facial paralysis 1 | 15
Substance abuse 1 | 55
Thyroiditis 1 | 25

Tissue

Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Nervous System 7 | 18,561
Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444
Respiratory system 5 | 17,484

Target Family

Non-IDG 7 | 11,971

Grant Application

5R01DK057561-02 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Pro-opiomelanocortin POMC Tbio Non-IDG -4.54944 36028.8 1100
Agouti-related protein AGRP Tbio Non-IDG -2.63067 471.4 168
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796
STAM-binding protein STAMBP Tbio Non-IDG -1.56922 41.9 178